Caregiver Experiences with the Introduction of Pentavalent Vaccines in Two Centers in Port Harcourt, South-South Nigeria

References (21)

1. 1 Essential Medical Statistics
2. 2 Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability? [DOI]
3. 3 Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants [DOI]
4. 4 Introduction of Haemophilus Influenzae type b (Hib) as pentavalent (DPT-HepB-Hib) vaccine in two states of India [DOI]
5. 5 Vaccines and immunization: The past, present and future in Nigeria [DOI]
6. 6 Factors influencing immunisation coverage in Mathare Valley, Nairobi [DOI]
7. 7 Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (PentaximTM) and monovalent hepatitis B vaccine at 6, 10 and 14 months of age in infants in South Africa [DOI]
8. 8 Sustaining GAVI-supported vaccine introductions in resource-poor countries [DOI]
9. 9 Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem ® demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine [DOI]
10. 10 The Social Determinants of Routine Immunisation in Ekiti State of Nigeria [DOI]
11. 11 A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants [DOI]
12. 12 THE KNOWLEDGE AND ATTITUDE TOWARDS CHILDHOOD IMMUNIZATION AMONGST MOTHERS ATTENDING ANTENATAL CLINIC IN LAGOS UNIVERSITY TEACHING HOSPITAL [DOI]
13. 13 Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine [DOI]
14. 14 Pentavalent vaccine [DOI]
15. 15 Community knowledge, attitude and practice of childhood immunization in Southwest Nigeria: Data from a Paediatric Association of Nigeria town hall meeting [DOI]
16. 16 Design and validation of the Satisfaction With Immunisation Service Questionnaire (SWISQ) [DOI]
17. 17 An Appraisal of Immunisation in Nigeria: Towards Improving Coverage [DOI]
18. 18 Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children.
19. 19 The safety advantages of pentavalent vaccines [DOI]
20. 20 A Review of Immunisation Policy and the African Child [DOI]
21. 21 Introducing pentavalent vaccine in EPI in India: a counsel for prudence in interpreting scientific literature.

Cited by 11

Showing 5 of 11 known citations — external sources report more than can currently be individually listed.

Related research

• How Poliomyelitis Eradication Interventions Have Affected the Knowledge, Attitudes and Uptake of Polio Vaccines among Nigerian Women — shares topic coverage
• Perceived Barriers to Immunization and Effective Strategies for Improving Uptake among Parents and Caregivers in Yobe State, Nigeria — shares topic coverage
• Salmonella Enteritidis Flagella may Enhance Attachment and Invasion of Hen Ovarian Granulosa Cells and Induce Protective Immune Response in Egg-laying Hens — shares topic coverage
• Advancing Hepatitis B Virus Testing in Prospective Blood Donors Beyond Current Single Marker Rapid Technique: Is it a Luxury or Necessity? — shares topic coverage
• Challenges in Providing Immunization Services amongst Community Pharmacists in South-south, Nigeria: A Cross-sectional Study — shares topic coverage